SEC Form 4 · accession 0001711462-26-000012
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul F. Lizzul
Officer — Chief Medical Officer
Period of report
Mar 12, 2026
Accepted (ET)
Aug 7, 2026 · 5:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001370053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Stock UnitsF1,F2,F3 | — | Mar 12, 2026 | A | 16,667 | A | — | — | Common Stock | 16,667 | 16,667 | D |
Explanation of responses
- F1Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on March 12, 2026.
- F2Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
- F3The PSUs vest and settle over two years; 50% vests on March 12, 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.